Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
22
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Huang James | Director | 22 | $1.32M | $0 | 2022-09-08 |
| Zukiwski Alexander A | EVP and Chief Medical Officer | 4 | $0 | $0 | 2022-09-07 |
| He Wei-Wu | Director, 10% Owner | 51 | $33.62M | $0 | 2022-06-15 |
| Wu Yue Alexander | Director | 4 | $0 | $0 | 2022-05-25 |
| Salisbury Franklin Cary jr | Director | 8 | $0 | $0 | 2022-05-25 |
| Zhou Quan | Director, 10% Owner | 7 | $0 | $0 | 2022-05-25 |
| SHROTRIYA RAJESH C MD | Director | 9 | $0 | $0 | 2022-05-25 |
| Zhang Larry | President | 3 | $38.3K | $0 | 2021-07-24 |
| Xu Weihao | Chief Financial Officer | 4 | $15.4K | $0 | 2020-12-17 |
| Wealth Strategy Holding Ltd | 10% Owner | 2 | $0 | $0 | 2019-12-30 |
| Ren Ken Keyong | Director | 13 | $10.9K | $0 | 2019-06-20 |
| Spectrum Pharmaceuticals Cayman, L.P. | 10% Owner | 9 | $29.3K | $0 | 2019-04-02 |
| Hu Cynthia W. | See Remarks | 17 | $12.1K | $0 | 2019-01-29 |
| Lin Dongliang | 10% Owner | 3 | $0 | $0 | 2018-11-13 |
| Chi George | Chief Financial Officer | 1 | $0 | $0 | 2018-09-28 |
| CAPITELLI SARA B | VP, Finance & PAO | 13 | $0 | $0 | 2018-07-12 |
| Wu Alex | Director | 4 | $0 | $0 | 2018-06-29 |
| IDG-Accel China Growth Fund GP III Associates Ltd. | 10% Owner | 8 | $12.65M | $0 | 2018-03-21 |
| SPECTRUM PHARMACEUTICALS INC | 10% Owner | 4 | $32.1K | $0 | 2017-12-22 |
| SPARKLE BYTE LTD | 10% Owner | 2 | $4.49M | $0 | 2016-06-24 |
| Mak Tak W. | Director | 2 | $0 | $0 | 2016-03-02 |
| Ren Ken | CEO and Director | 4 | $10.9K | $0 | 2016-01-19 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Huang James | Director | P Buy | 2022-09-08 | 2022-09-08 | 33,300 | $4.28 | $142.5K | 371,517 | SEC↗ |
| Zukiwski Alexander A | EVP and Chief Medical Office | A Award deriv | 2022-09-07 | 2022-09-09 | 3,000 | — | $0 | 3,000 | SEC↗ |
| Huang James | Director | P Buy | 2022-09-07 | 2022-09-08 | 3,111 | $4.00 | $12.4K | 338,217 | SEC↗ |
| Huang James | Director | P Buy | 2022-09-06 | 2022-09-08 | 19,162 | $3.89 | $74.5K | 335,106 | SEC↗ |
| Huang James | Director | P Buy | 2022-09-02 | 2022-09-02 | 400 | $3.74 | $1.5K | 315,944 | SEC↗ |
| Huang James | Director | P Buy | 2022-09-01 | 2022-09-02 | 11,821 | $3.72 | $44.0K | 315,544 | SEC↗ |
| Huang James | Director | P Buy | 2022-08-31 | 2022-09-02 | 24,975 | $3.75 | $93.7K | 303,723 | SEC↗ |
| Huang James | Director | P Buy | 2022-08-26 | 2022-08-26 | 39,527 | $3.75 | $148.2K | 278,748 | SEC↗ |
| Huang James | Director | P Buy | 2022-08-24 | 2022-08-26 | 5,000 | $3.75 | $18.8K | 239,221 | SEC↗ |
| Huang James | Director | P Buy | 2022-08-23 | 2022-08-23 | 40,000 | $3.50 | $140.0K | 234,221 | SEC↗ |
| Huang James | Director | P Buy | 2022-08-22 | 2022-08-23 | 23,105 | $3.46 | $79.9K | 194,221 | SEC↗ |
| Huang James | Director | P Buy | 2022-08-19 | 2022-08-23 | 171,116 | $3.27 | $559.5K | 171,116 | SEC↗ |
| He Wei-Wu | Chairman and CEO | P Buy | 2022-06-15 | 2022-06-17 | 50,000 | $3.18 | $159.0K | 644,553 | SEC↗ |
| He Wei-Wu | Chairman and CEO | P Buy | 2022-06-14 | 2022-06-17 | 2,096 | $3.06 | $6.4K | 594,553 | SEC↗ |
| He Wei-Wu | Chairman and CEO | P Buy | 2022-06-13 | 2022-06-17 | 36,058 | $2.97 | $107.1K | 592,457 | SEC↗ |
| SHROTRIYA RAJESH C MD | Director | A Award deriv | 2022-05-25 | 2022-05-26 | 345,806 | — | $0 | 345,806 | SEC↗ |
| Salisbury Franklin Cary jr | Director | A Award deriv | 2022-05-25 | 2022-05-26 | 388,387 | — | $0 | 388,387 | SEC↗ |
| Wu Yue Alexander | Director | A Award deriv | 2022-05-25 | 2022-05-26 | 388,387 | — | $0 | 388,387 | SEC↗ |
| Huang James | Director | A Award deriv | 2022-05-25 | 2022-05-26 | 397,419 | — | $0 | 397,419 | SEC↗ |
| Zhou Quan | Director | A Award deriv | 2022-05-25 | 2022-05-26 | 380,645 | — | $0 | 380,645 | SEC↗ |
| Zukiwski Alexander A | Chief Medical Officer | A Award deriv | 2021-12-02 | 2021-12-06 | 500,000 | — | $0 | 500,000 | SEC↗ |
| He Wei-Wu | Chairman and CEO | P Buy | 2021-11-18 | 2021-11-19 | 200,000 | $0.98 | $196.0K | 5,558,472 | SEC↗ |
| He Wei-Wu | Chairman and CEO | P Buy | 2021-11-17 | 2021-11-19 | 200,000 | $0.99 | $198.0K | 5,362,569 | SEC↗ |
| He Wei-Wu | Chairman and CEO | P Buy | 2021-08-19 | 2021-08-20 | 180,000 | $1.26 | $226.8K | 5,163,994 | SEC↗ |
| He Wei-Wu | Chairman and CEO | P Buy | 2021-08-18 | 2021-08-20 | 300,000 | $1.29 | $387.0K | 4,983,994 | SEC↗ |
| Zhang Larry | President | A Award deriv | 2021-07-24 | 2021-07-26 | 800,000 | — | $0 | 800,000 | SEC↗ |
| He Wei-Wu | Chairman and CEO | A Award deriv | 2021-06-15 | 2021-06-16 | 4,000,000 | — | $0 | 4,000,000 | SEC↗ |
| Huang James | Director | A Award deriv | 2021-06-15 | 2021-06-16 | 113,028 | — | $0 | 113,028 | SEC↗ |
| Salisbury Franklin Cary jr | Director | A Award deriv | 2021-06-15 | 2021-06-16 | 110,459 | — | $0 | 110,459 | SEC↗ |
| SHROTRIYA RAJESH C MD | Director | A Award deriv | 2021-06-15 | 2021-06-16 | 98 | — | $0 | 98,349 | SEC↗ |
| Wu Yue Alexander | Director | A Award deriv | 2021-06-15 | 2021-06-16 | 110,459 | — | $0 | 110,459 | SEC↗ |
| Zhou Quan | Director | A Award deriv | 2021-06-15 | 2021-06-16 | 108,257 | — | $0 | 108,257 | SEC↗ |
| He Wei-Wu | Chairman and CEO | P Buy | 2021-03-26 | 2021-03-30 | 3,000,000 | $2.05 | $6.15M | 3,000,000 | SEC↗ |
| He Wei-Wu | Chairman and CEO | G Gift | 2020-12-22 | 2020-12-23 | 380,000 | — | $0 | 4,683,994 | SEC↗ |
| Xu Weihao | Chief Financial Officer | P Buy | 2020-12-17 | 2020-12-18 | 2,279 | $2.63 | $6.0K | 10,000 | SEC↗ |
| Xu Weihao | Chief Financial Officer | P Buy | 2020-12-17 | 2020-12-18 | 1,721 | $2.64 | $4.5K | 7,721 | SEC↗ |
| Xu Weihao | Chief Financial Officer | A Award deriv | 2020-12-16 | 2020-12-18 | 800,000 | — | $0 | 800,000 | SEC↗ |
| Xu Weihao | Chief Financial Officer | P Buy | 2020-12-16 | 2020-12-18 | 2,000 | $2.44 | $4.9K | 6,000 | SEC↗ |
| He Wei-Wu | Chairman and CEO | P Buy | 2020-11-23 | 2020-11-24 | 100,000 | $2.18 | $218.0K | 5,063,994 | SEC↗ |
| He Wei-Wu | Chairman and CEO | P Buy | 2020-11-20 | 2020-11-24 | 127,471 | $2.12 | $270.2K | 4,963,994 | SEC↗ |
| He Wei-Wu | Chairman and CEO | P Buy | 2020-07-22 | 2020-07-24 | 2,952,426 | $1.90 | $5.61M | 4,836,523 | SEC↗ |
| He Wei-Wu | Chairman and CEO | P Buy | 2020-07-22 | 2020-07-24 | 1,200,000 | $1.90 | $2.28M | 7,532,347 | SEC↗ |
| Zhang Larry | President | P Buy | 2020-07-22 | 2020-07-24 | 20,153 | $1.90 | $38.3K | 20,153 | SEC↗ |
| SHROTRIYA RAJESH C MD | Director | A Award deriv | 2020-06-16 | 2020-06-18 | 61,257 | — | $0 | 61,257 | SEC↗ |
| Salisbury Franklin Cary jr | Director | A Award deriv | 2020-06-16 | 2020-06-18 | 68,800 | — | $0 | 68,800 | SEC↗ |
| Wu Yue Alexander | Director | A Award deriv | 2020-06-16 | 2020-06-18 | 68,800 | — | $0 | 68,800 | SEC↗ |
| Huang James | Director | A Award deriv | 2020-06-16 | 2020-06-18 | 70,400 | — | $0 | 70,400 | SEC↗ |
| Zhou Quan | Director | A Award deriv | 2020-06-16 | 2020-06-18 | 67,429 | — | $0 | 67,429 | SEC↗ |
| He Wei-Wu | Chairman and CEO | P Buy | 2020-05-20 | 2020-05-21 | 56,464 | $2.37 | $133.8K | 1,884,097 | SEC↗ |
| He Wei-Wu | Chairman and CEO | P Buy | 2020-05-19 | 2020-05-21 | 29,801 | $2.03 | $60.5K | 1,827,663 | SEC↗ |
| He Wei-Wu | Chairman and CEO | P Buy | 2020-05-18 | 2020-05-19 | 338,932 | $2.02 | $684.6K | 1,797,832 | SEC↗ |
| He Wei-Wu | Chairman and CEO | P Buy | 2020-05-15 | 2020-05-19 | 100,000 | $1.82 | $182.0K | 1,458,900 | SEC↗ |
| He Wei-Wu | Chairman and CEO | P Buy | 2020-03-27 | 2020-03-30 | 6,880 | $2.08 | $14.3K | 1,358,900 | SEC↗ |
| He Wei-Wu | Chairman and CEO | P Buy | 2020-03-26 | 2020-03-27 | 328,095 | $2.09 | $685.7K | 1,352,020 | SEC↗ |
| He Wei-Wu | Chairman and CEO | P Buy | 2020-03-25 | 2020-03-27 | 196,398 | $1.94 | $381.0K | 1,023,925 | SEC↗ |
| He Wei-Wu | Chairman and CEO | P Buy | 2020-03-19 | 2020-03-19 | 234,488 | $1.57 | $368.1K | 6,332,347 | SEC↗ |
| He Wei-Wu | Chairman and CEO | P Buy | 2020-03-18 | 2020-03-19 | 501,322 | $1.52 | $762.0K | 6,097,859 | SEC↗ |
| He Wei-Wu | Chairman and CEO | P Buy | 2020-03-17 | 2020-03-19 | 264,192 | $1.50 | $396.3K | 5,596,537 | SEC↗ |
| Wealth Strategy Holding Ltd | 10% Owner | X Exercise deriv | 2019-12-30 | 2020-01-06 | 493,827 | $0.13 | $64.2K | 0 | SEC↗ |
| Wealth Strategy Holding Ltd | 10% Owner | X Exercise | 2019-12-30 | 2020-01-06 | 493,827 | $1.69 | $834.6K | 9,087,888 | SEC↗ |
| He Wei-Wu | Chairman and CEO | X Exercise deriv | 2019-12-16 | 2019-12-18 | 374,321 | — | $0 | 0 | SEC↗ |
| He Wei-Wu | Chairman and CEO | X Exercise | 2019-12-16 | 2019-12-18 | 374,321 | $1.69 | $632.6K | 5,332,345 | SEC↗ |
| Zukiwski Alexander A | Chief Medical Officer | A Award deriv | 2019-12-15 | 2019-12-17 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Zhang Larry | President | A Award deriv | 2019-09-20 | 2019-09-24 | 200,000 | — | $0 | 200,000 | SEC↗ |
| He Wei-Wu | Chief Executive Officer | P Buy | 2019-08-16 | 2019-08-20 | 20,000 | $3.20 | $64.0K | 827,527 | SEC↗ |
| He Wei-Wu | Chief Executive Officer | P Buy | 2019-08-14 | 2019-08-15 | 160,000 | $3.17 | $507.2K | 807,527 | SEC↗ |
| Huang James | Director | A Award deriv | 2019-06-20 | 2019-06-21 | 59,231 | — | $0 | 59,231 | SEC↗ |
| SHROTRIYA RAJESH C MD | Director | A Award deriv | 2019-06-20 | 2019-06-21 | 51,538 | — | $0 | 51,538 | SEC↗ |
| Wu Yue Alexander | Director | A Award deriv | 2019-06-20 | 2019-06-21 | 57,885 | — | $0 | 57,885 | SEC↗ |
| Zhou Quan | Director, 10% Owner | A Award deriv | 2019-06-20 | 2019-06-21 | 56,731 | — | $0 | 56,731 | SEC↗ |
| Ren Ken Keyong | Director | A Award deriv | 2019-06-20 | 2019-06-21 | 51,538 | — | $0 | 51,538 | SEC↗ |
| Salisbury Franklin Cary jr | Director | A Award deriv | 2019-06-20 | 2019-06-21 | 57,885 | — | $0 | 57,885 | SEC↗ |
| He Wei-Wu | CEO | A Award deriv | 2019-06-20 | 2019-06-21 | 4,000,000 | — | $0 | 4,000,000 | SEC↗ |
| Spectrum Pharmaceuticals Cayma | 10% Owner | J Other | 2019-04-02 | 2019-04-04 | 1,500,000 | $3.38 | $5.07M | 5,397,413 | SEC↗ |
| Hu Cynthia W. | COO, Gen Counsel & Secretary | A Award deriv | 2019-01-29 | 2019-01-31 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Ren Ken Keyong | Chief Executive Officer | A Award deriv | 2019-01-29 | 2019-01-31 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Hu Cynthia W. | COO, Gen Counsel & Secretary | M Exercise deriv | 2019-01-14 | 2019-01-15 | 15,000 | — | $0 | 0 | SEC↗ |
| Hu Cynthia W. | COO, Gen Counsel & Secretary | F Tax w/h | 2019-01-14 | 2019-01-15 | 3,100 | $3.79 | $11.7K | 29,685 | SEC↗ |
| Hu Cynthia W. | COO, Gen Counsel & Secretary | M Exercise | 2019-01-14 | 2019-01-15 | 15,000 | $1.76 | $26.4K | 32,785 | SEC↗ |
| He Wei-Wu | Director, 10% Owner | G Gift | 2018-12-19 | 2018-12-21 | 200,000 | — | $0 | 647,527 | SEC↗ |
| Ren Ken Keyong | Chief Executive Officer | A Award deriv | 2018-12-03 | 2018-12-06 | 720,000 | — | $0 | 720,000 | SEC↗ |
| Lin Dongliang | 10% Owner | X Exercise deriv | 2018-11-13 | 2018-11-14 | 948,982 | $0.13 | $123.4K | 0 | SEC↗ |
| Lin Dongliang | 10% Owner | X Exercise deriv | 2018-11-13 | 2018-11-14 | 750,771 | $0.13 | $97.6K | 0 | SEC↗ |
| Lin Dongliang | 10% Owner | X Exercise | 2018-11-13 | 2018-11-14 | 1,699,753 | $1.69 | $2.87M | 10,198,518 | SEC↗ |
| Chi George | Chief Financial Officer | A Award deriv | 2018-09-28 | 2018-10-02 | 400,000 | — | $0 | 400,000 | SEC↗ |
| CAPITELLI SARA B | VP Fin & Principal Account O | M Exercise deriv | 2018-07-12 | 2018-07-13 | 35,000 | — | $0 | 0 | SEC↗ |
| CAPITELLI SARA B | VP Fin & Principal Account O | M Exercise | 2018-07-12 | 2018-07-13 | 35,000 | $1.99 | $69.7K | 35,000 | SEC↗ |
| CAPITELLI SARA B | VP Fin & Principal Account O | D To issuer | 2018-07-12 | 2018-07-13 | 26,600 | $7.49 | $199.2K | 0 | SEC↗ |
| CAPITELLI SARA B | VP Fin & Principal Account O | F Tax w/h | 2018-07-12 | 2018-07-13 | 8,400 | $7.49 | $62.9K | 26,600 | SEC↗ |
| Wu Alex | Director | A Award deriv | 2018-06-29 | 2018-07-03 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Salisbury Franklin Cary jr | Director | A Award deriv | 2018-06-29 | 2018-07-03 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Zhou Quan | Director, 10% Owner | A Award deriv | 2018-06-29 | 2018-07-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Huang James | Director | A Award deriv | 2018-06-29 | 2018-07-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SHROTRIYA RAJESH C MD | Director | A Award deriv | 2018-06-29 | 2018-07-03 | 35,000 | — | $0 | 35,000 | SEC↗ |
| He Wei-Wu | Director, 10% Owner | A Award deriv | 2018-06-11 | 2018-06-12 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| CAPITELLI SARA B | VP Fin & Principal Account O | M Exercise deriv | 2018-04-12 | 2018-04-13 | 26,978 | — | $0 | 0 | SEC↗ |
| CAPITELLI SARA B | VP Fin & Principal Account O | D To issuer | 2018-04-12 | 2018-04-13 | 18,778 | $6.62 | $124.3K | 0 | SEC↗ |
| CAPITELLI SARA B | VP Fin & Principal Account O | F Tax w/h | 2018-04-12 | 2018-04-13 | 8,200 | $6.62 | $54.3K | 18,778 | SEC↗ |
| CAPITELLI SARA B | VP Fin & Principal Account O | M Exercise | 2018-04-12 | 2018-04-13 | 26,978 | $0.88 | $23.7K | 26,978 | SEC↗ |
| Huang James | Director | J Other | 2018-04-04 | 2018-04-06 | 191 | — | $0 | 191 | SEC↗ |
| Huang James | Director | J Other | 2018-04-04 | 2018-04-06 | 416,666 | — | $0 | 0 | SEC↗ |
| IDG-Accel China Growth Fund GP | 10% Owner | P Buy deriv | 2018-03-21 | 2018-03-23 | 1,152,839 | $0.13 | $149.9K | 81,728 | SEC↗ |
| IDG-Accel China Growth Fund GP | 10% Owner | P Buy deriv | 2018-03-21 | 2018-03-23 | 1,152,839 | $0.13 | $149.9K | 1,152,839 | SEC↗ |
| IDG-Accel China Growth Fund GP | 10% Owner | P Buy | 2018-03-21 | 2018-03-23 | 2,882,098 | $3.19 | $9.19M | 9,126,375 | SEC↗ |
| IDG-Accel China Growth Fund GP | 10% Owner | P Buy | 2018-03-21 | 2018-03-23 | 204,320 | $3.19 | $651.8K | 646,995 | SEC↗ |
| He Wei-Wu | Director, 10% Owner | A Award deriv | 2018-03-19 | 2018-03-21 | 1,234,567 | — | $0 | 1,234,567 | SEC↗ |
| He Wei-Wu | Director, 10% Owner | P Buy | 2018-03-19 | 2018-03-21 | 3,086,419 | $3.24 | $10.00M | 4,958,024 | SEC↗ |
| SPECTRUM PHARMACEUTICALS INC | 10% Owner | P Buy | 2017-12-22 | 2017-12-22 | 907,356 | $0.01 | $9.1K | 6,897,413 | SEC↗ |
| SPECTRUM PHARMACEUTICALS INC | 10% Owner | P Buy | 2017-12-22 | 2017-12-22 | 611,740 | $0.01 | $6.1K | 4,650,262 | SEC↗ |
| He Wei-Wu | Director | P Buy | 2017-10-10 | 2017-10-11 | 100,000 | $1.95 | $195.0K | 847,527 | SEC↗ |
| He Wei-Wu | Director | P Buy | 2017-10-06 | 2017-10-10 | 100,000 | $1.86 | $186.0K | 747,527 | SEC↗ |
| He Wei-Wu | Director | P Buy | 2017-10-05 | 2017-10-10 | 100,000 | $1.80 | $180.0K | 647,527 | SEC↗ |
| Hu Cynthia W. | COO, Gen Counsel and Secreta | A Award deriv | 2017-09-29 | 2017-10-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CAPITELLI SARA B | VP Fin & Principal Account O | A Award deriv | 2017-09-29 | 2017-10-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| He Wei-Wu | Director | P Buy | 2017-09-19 | 2017-09-20 | 34,002 | $1.78 | $60.5K | 547,527 | SEC↗ |
| He Wei-Wu | Director | P Buy | 2017-09-18 | 2017-09-20 | 173,500 | $1.75 | $303.6K | 513,525 | SEC↗ |
| He Wei-Wu | Director | P Buy | 2017-09-15 | 2017-09-18 | 127,702 | $1.49 | $190.3K | 340,025 | SEC↗ |
| He Wei-Wu | Director | P Buy | 2017-09-14 | 2017-09-18 | 187,625 | $1.22 | $228.9K | 212,323 | SEC↗ |
| Hu Cynthia W. | COO, Gen Counsel and Secreta | A Award deriv | 2017-07-10 | 2017-10-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CAPITELLI SARA B | VP Fin & Principal Account O | A Award deriv | 2017-06-08 | 2017-06-09 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Hu Cynthia W. | COO, Gen Counsel and Secreta | A Award deriv | 2017-06-08 | 2017-06-09 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Zhou Quan | Director, 10% Owner | A Award deriv | 2017-06-08 | 2017-06-09 | 50,000 | — | $0 | 50,000 | SEC↗ |
| He Wei-Wu | Director | A Award deriv | 2017-06-08 | 2017-06-09 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Huang James | Director | A Award deriv | 2017-06-08 | 2017-06-09 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Salisbury Franklin Cary jr | Director | A Award deriv | 2017-06-08 | 2017-06-09 | 35,000 | — | $0 | 35,000 | SEC↗ |
| SHROTRIYA RAJESH C MD | Director | A Award deriv | 2017-06-08 | 2017-06-09 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Wu Alex | Director | A Award deriv | 2017-06-08 | 2017-06-09 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Zukiwski Alexander A | Chief Medical Officer | A Award deriv | 2017-04-03 | 2017-04-05 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Spectrum Pharmaceuticals Cayma | 10% Owner | P Buy | 2016-10-28 | 2016-11-01 | 521,692 | $0.01 | $5.2K | 3,839,757 | SEC↗ |
| Spectrum Pharmaceuticals Cayma | 10% Owner | P Buy | 2016-10-28 | 2016-11-01 | 198,765 | $0.01 | $2.0K | 4,038,522 | SEC↗ |
| Spectrum Pharmaceuticals Cayma | 10% Owner | P Buy | 2016-10-28 | 2016-11-01 | 773,790 | $0.01 | $7.7K | 5,695,242 | SEC↗ |
| Spectrum Pharmaceuticals Cayma | 10% Owner | P Buy | 2016-10-28 | 2016-11-01 | 294,815 | $0.01 | $2.9K | 5,990,057 | SEC↗ |
| He Wei-Wu | Director | A Award deriv | 2016-10-24 | 2016-10-25 | 202,247 | — | $0 | 202,247 | SEC↗ |
| Ren Ken Keyong | Chief Executive Officer | A Award deriv | 2016-10-03 | 2016-10-05 | 308,571 | — | $0 | 308,571 | SEC↗ |
| He Wei-Wu | Director | A Award deriv | 2016-10-03 | 2016-10-05 | 374,321 | $0.03 | $11.2K | 374,321 | SEC↗ |
| He Wei-Wu | Director | A Award deriv | 2016-10-03 | 2016-10-05 | 366,343 | — | $0 | 366,343 | SEC↗ |
| He Wei-Wu | Director | P Buy | 2016-10-03 | 2016-10-05 | 1,871,605 | $1.19 | $2.23M | 1,871,605 | SEC↗ |
| Spectrum Pharmaceuticals Cayma | 10% Owner | P Buy | 2016-07-20 | 2016-08-16 | 98,271 | $0.01 | $983 | 4,921,452 | SEC↗ |
| Spectrum Pharmaceuticals Cayma | 10% Owner | P Buy | 2016-07-20 | 2016-08-16 | 66,255 | $0.01 | $663 | 3,318,065 | SEC↗ |
| Spectrum Pharmaceuticals Cayma | 10% Owner | P Buy | 2016-07-14 | 2016-08-16 | 394,942 | $0.01 | $3.9K | 3,251,810 | SEC↗ |
| Spectrum Pharmaceuticals Cayma | 10% Owner | P Buy | 2016-07-14 | 2016-08-16 | 585,790 | $0.01 | $5.9K | 4,823,181 | SEC↗ |
| He Wei-Wu | Director | A Award deriv | 2016-07-05 | 2016-07-06 | 84,507 | — | $0 | 84,507 | SEC↗ |
| He Wei-Wu | Director | A Award deriv | 2016-06-24 | 2016-06-27 | 369,805 | — | $0 | 369,805 | SEC↗ |
| Hu Cynthia W. | COO, Gen Counsel & Secretary | A Award deriv | 2016-06-24 | 2016-06-27 | 27,027 | — | $0 | 27,027 | SEC↗ |
| Ren Ken Keyong | Chief Executive Officer | A Award deriv | 2016-06-24 | 2016-06-27 | 86,486 | — | $0 | 86,486 | SEC↗ |
| SPARKLE BYTE LTD | 10% Owner | P Buy deriv | 2016-06-24 | 2016-06-29 | 750,771 | $0.03 | $22.5K | 1,699,753 | SEC↗ |
| SPARKLE BYTE LTD | 10% Owner | P Buy | 2016-06-24 | 2016-06-29 | 3,753,855 | $1.19 | $4.47M | 8,498,765 | SEC↗ |
| He Wei-Wu | Director | A Award deriv | 2016-06-02 | 2016-06-03 | 712,112 | — | $0 | 712,112 | SEC↗ |
| Hu Cynthia W. | COO, Gen Counsel & Secretary | A Award deriv | 2016-06-02 | 2016-06-03 | 87,719 | — | $0 | 87,719 | SEC↗ |
| Ren Ken Keyong | Chief Executive Officer | A Award deriv | 2016-06-02 | 2016-06-03 | 280,701 | — | $0 | 280,701 | SEC↗ |
| Zhou Quan | Director, 10% Owner | A Award deriv | 2016-06-02 | 2016-06-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Hu Cynthia W. | COO, Gen Counsel and Secreta | A Award deriv | 2016-03-02 | 2016-03-04 | 95,000 | — | $0 | 95,000 | SEC↗ |
| Mak Tak W. | Director | A Award deriv | 2016-03-02 | 2016-03-04 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Huang James | Director | A Award deriv | 2016-03-02 | 2016-03-04 | 75,000 | — | $0 | 75,000 | SEC↗ |
| CAPITELLI SARA B | VP Fin & Principal Account O | A Award deriv | 2016-03-02 | 2016-03-04 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Ren Ken Keyong | Chief Executive Officer | A Award deriv | 2016-03-02 | 2016-03-04 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Salisbury Franklin Cary jr | Director | A Award deriv | 2016-03-02 | 2016-03-04 | 35,000 | — | $0 | 35,000 | SEC↗ |
| SHROTRIYA RAJESH C MD | Director | A Award deriv | 2016-03-02 | 2016-03-04 | 35,000 | — | $0 | 35,000 | SEC↗ |
| He Wei-Wu | Director | A Award deriv | 2016-03-02 | 2016-03-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Wu Alex | Director | A Award deriv | 2016-03-02 | 2016-03-04 | 35,000 | — | $0 | 35,000 | SEC↗ |
| SPECTRUM PHARMACEUTICALS INC | 10% Owner | P Buy | 2016-02-22 | 2016-03-11 | 680,113 | $0.01 | $6.8K | 2,856,868 | SEC↗ |
| SPECTRUM PHARMACEUTICALS INC | 10% Owner | P Buy | 2016-02-22 | 2016-03-11 | 1,008,764 | $0.01 | $10.1K | 4,237,391 | SEC↗ |
| Hu Cynthia W. | COO | P Buy | 2016-01-19 | 2016-01-21 | 11,837 | $0.72 | $8.5K | 17,785 | SEC↗ |
| Hu Cynthia W. | COO | P Buy | 2016-01-19 | 2016-01-21 | 400 | $0.75 | $300 | 1,785 | SEC↗ |
| Hu Cynthia W. | COO | P Buy | 2016-01-19 | 2016-01-21 | 400 | $0.75 | $300 | 1,385 | SEC↗ |
| Hu Cynthia W. | COO | P Buy | 2016-01-19 | 2016-01-21 | 4,163 | $0.72 | $3.0K | 5,948 | SEC↗ |
| Ren Ken | CEO and Director | P Buy | 2016-01-19 | 2016-01-21 | 1,100 | $0.74 | $814 | 8,637 | SEC↗ |
| Ren Ken | CEO and Director | P Buy | 2016-01-19 | 2016-01-21 | 300 | $0.71 | $213 | 15,000 | SEC↗ |
| Ren Ken | CEO and Director | P Buy | 2016-01-19 | 2016-01-21 | 7,537 | $0.73 | $5.5K | 7,537 | SEC↗ |
| Ren Ken | CEO and Director | P Buy | 2016-01-19 | 2016-01-21 | 6,063 | $0.72 | $4.4K | 14,700 | SEC↗ |
| Ren Ken Keyong | CEO and Director | P Buy | 2016-01-19 | 2016-01-21 | 7,537 | $0.73 | $5.5K | 7,537 | SEC↗ |
| Ren Ken Keyong | CEO and Director | P Buy | 2016-01-19 | 2016-01-21 | 1,100 | $0.74 | $814 | 8,637 | SEC↗ |
| Ren Ken Keyong | CEO and Director | P Buy | 2016-01-19 | 2016-01-21 | 6,063 | $0.72 | $4.4K | 14,700 | SEC↗ |
| Ren Ken Keyong | CEO and Director | P Buy | 2016-01-19 | 2016-01-21 | 300 | $0.71 | $213 | 15,000 | SEC↗ |
| Hu Cynthia W. | See Remarks | A Award deriv | 2015-04-06 | 2015-04-08 | 175,000 | — | $0 | 175,000 | SEC↗ |
| Mak Tak W. | Director | A Award deriv | 2015-04-06 | 2015-04-08 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Huang James | Director | A Award deriv | 2015-04-06 | 2015-04-08 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Wu Alex | Director | A Award deriv | 2015-04-06 | 2015-04-08 | 35,000 | — | $0 | 35,000 | SEC↗ |
| CAPITELLI SARA B | See Remarks | A Award deriv | 2015-04-06 | 2015-04-08 | 65,000 | — | $0 | 65,000 | SEC↗ |
| He Wei-Wu | Director | A Award deriv | 2015-04-06 | 2015-04-08 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Ren Ken Keyong | Chief Executive Officer | A Award deriv | 2015-04-06 | 2015-04-08 | 225,000 | — | $0 | 225,000 | SEC↗ |
| Salisbury Franklin Cary jr | Director | A Award deriv | 2015-04-06 | 2015-04-08 | 35,000 | — | $0 | 35,000 | SEC↗ |
| SHROTRIYA RAJESH C MD | Director | A Award deriv | 2015-04-06 | 2015-04-08 | 35,000 | — | $0 | 35,000 | SEC↗ |
| SHROTRIYA RAJESH C MD | Director | A Award deriv | 2014-09-22 | 2014-09-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Hu Cynthia W. | See Remarks | A Award deriv | 2014-04-03 | 2014-11-14 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Huang James | Director | A Award deriv | 2014-04-03 | 2014-11-14 | 100,000 | — | $0 | 100,000 | SEC↗ |
| He Wei-Wu | Director | A Award deriv | 2014-04-03 | 2014-11-14 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Ren Ken Keyong | Chief Executive Officer | A Award deriv | 2014-04-03 | 2014-11-14 | 100,000 | — | $0 | 100,000 | SEC↗ |
| IDG-Accel China Growth Fund GP | 10% Owner | P Buy deriv | 2013-03-07 | 2016-01-27 | 34,479 | — | $0 | 92,044 | SEC↗ |
| IDG-Accel China Growth Fund GP | 10% Owner | P Buy deriv | 2013-03-07 | 2016-01-27 | 486,354 | — | $0 | 1,298,354 | SEC↗ |
| IDG-Accel China Growth Fund GP | 10% Owner | P Buy | 2013-03-07 | 2016-01-27 | 68,958 | $2.40 | $165.5K | 360,947 | SEC↗ |
| IDG-Accel China Growth Fund GP | 10% Owner | P Buy | 2013-03-07 | 2016-01-27 | 972,708 | $2.40 | $2.33M | 5,091,438 | SEC↗ |
| CAPITELLI SARA B | VP, Finance & PAO | A Award deriv | 2012-08-15 | 2014-11-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Hu Cynthia W. | See Remarks | A Award deriv | 2012-08-15 | 2014-11-14 | 50,000 | — | $0 | 50,000 | SEC↗ |